Cerevel Therapeutics Holdings, Inc. Common Stock

CERE

Market cap $8.19B

Delisted

CERE was delisted on the 31st of July, 2024.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	GL 1 Governors Lane New York	$7.56M	+$7.63M	+723,104	New
2	6CM 2 683 Capital Management New York	$7.32M	+$7.39M	+700,000	New
3	SRCM 3 Sage Rock Capital Management New York	$3.41M	+$3.44M	+326,067	New
4	4 Adage Capital Partners Boston, Massachusetts	$3.13M	+$3.17M	+300,000	New
5	CCM 5 Context Capital Management Lajolla, California	$2.82M	+$2.85M	+270,000	New
6	CPF 6 Context Partners Fund La Jolla, California	$2.82M	+$2.85M	+270,000	New
7	7 Alyeska Investment Group Chicago, Illinois	$2.26M	+$2.28M	+216,453	New
8	8 Hudson Bay Capital Management Stamford, Connecticut	$1.61M	+$1.62M	+153,984	New
9	SCM 9 Suvretta Capital Management New York	$1.57M	+$1.58M	+150,000	New
10	CCA 10 Castle Creek Arbitrage Avon, Colorado	$1.54M	+$1.55M	+147,156	New
11	LA 11 Linden Advisors New York	$419K	+$422K	+40,000	New
12	AA 12 AQR Arbitrage Greenwich, Connecticut	$418K	+$422K	+39,999	New
13	DCM 13 Dupont Capital Management Wilmington, Delaware	$418K	+$422K	+39,999	New
14	14 Verition Fund Management Greenwich, Connecticut	$308K	+$311K	+29,501	New
15	WAM 15 Wolverine Asset Management Chicago, Illinois	$276K	+$279K	+26,470	New
16	CAC 16 Cowen and Company New York	$146K	+$148K	+14,000	New
17	17 Creative Planning Overland Park, Kansas	$140K	+$141K	+13,400	New
18	FIA 18 FNY Investment Advisers New York	$53K	+$54.5K	+5,166	New